Navigation Links
GSK to Announce Q2 Results July 22, 2009
Date:7/16/2009

PHILADELPHIA, July 16 /PRNewswire-FirstCall/ -- On Wednesday, July 22nd, GlaxoSmithKline plc (NYSE: GSK) will announce its second quarter financial results for the three months ended June 30, 2009. It is anticipated that the announcement will be released to the London Stock Exchange at approximately 7:00 AM EDT.

Following the announcement, Andrew Witty, Chief Executive Officer, Julian Heslop, Chief Financial Officer and Moncef Slaoui, Chairman R&D will hold a briefing meeting for analysts and investors.

Webcast /Teleconferece Details

At 9.00 AM EDT a live webcast of the meeting, with synchronized slides, will be available on the GlaxoSmithKline corporate website www.gsk.com. A teleconference line will also be available and will enable you to listen in to the live presentation and Q&A session.

To listen to the teleconference dial:

US Toll Free Phone + 1 866 804 8688

Please quote: GSK Second Quarter Results

At approximately 4:00 pm EDT the webcast will be available as a replay version at www.gsk.com.


'/>"/>
SOURCE GlaxoSmithKline plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
11. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... July 24, 2017 , ... “Journey to the Light: The Quest ... details a young woman’s path to finding herself. “Journey to the Light: The ... author, Jamie Grayson, an experienced writer of newsletters, manuals, and articles, who has recently ...
(Date:7/23/2017)... Pekin, IL (PRWEB) , ... ... ... Association of Eating Disorders Professionals ™(iaedp), the leading provider of education and ... of training in preparation for competency for Traditional Certification: the iaedp™ Core ...
(Date:7/23/2017)... ... July 23, 2017 , ... Better education to coaches ... presenting their work today at the American Orthopaedic Society for Sports Medicine’ ... first one to prospectively document the association between sports specialization and lower extremity ...
(Date:7/23/2017)... ... 2017 , ... “I Am Not Nothin’: The Serpent Handler’s Daughter” is a ... and write and a brokenhearted young soldier who turned to whiskey after his return ... the power of simple faith is the work of published author Tommy G. Robertson, ...
(Date:7/23/2017)... ... July 23, 2017 , ... Viora ... grant of US Patent No. 9,038,640 by the United States Patent and Trademark ... together the combination of Switching, Vacuum, and Cooling mechanisms to further increase the ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July 21, ... UTHR ) announced today that it will report its ... on Thursday, July 27, 2017. ... Thursday, July 27, 2017, at 9:00 a.m. Eastern Time.  ... callers dialing 1-970-315-0533.  A rebroadcast of the teleconference will ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology: